Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CV scientists describe novel fatty acid oxidation inhibitors

Sep. 7, 2004

New evidence on the association between Lp-PLA2 and the risk of CHD and stroke

Sep. 7, 2004

Dronedarone found to reduce the risk of recurrence of atrial fibrillation or flutter

Sep. 6, 2004

Long-term improvements found with sitaxsentan in PAH patients

Sep. 6, 2004

Statin therapy reduces cardiovascular risk in type 2 diabetes

Sep. 6, 2004

New NO-donating rapamycin derivatives described by NitroMed

Sep. 3, 2004

JTE-607 induces cardioprotective effects in a rat model of ischemia and reperfusion

Sep. 3, 2004

Phase I/II trial for EW-A-401

Sep. 2, 2004

Novel MIF ligands and their use covered by Takeda patent

Sep. 2, 2004

Benefits of atorvastatin in the prevention of recurrent cardiovascular events after ACS

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...